BMRN
Biomarin Pharmaceutical Inc
60.30$
-1.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.50 | -1.39 | -1.37 | -0.05 | 0.11 | 0.27 | 0.45 | 1.67 | 0.93 | 0.83 | 2.91 | 4.19 | |
| 0.39 | 0.29 | 0.58 | 0.50 | 0.54 | 0.59 | 0.55 | 0.59 | 0.54 | 0.54 | 0.49 | 0.40 | |
| 0.60 | 0.70 | 0.81 | 0.80 | 0.84 | 0.89 | 0.99 | 1.08 | 1.04 | 1.08 | 1.02 | 0.92 | |
| 0.18 | -0.88 | 2.80 | 0.45 | 0.11 | 0.32 | -3.50 | 1.01 | 0.15 | – | – | – | |
| -0.21 | 0.29 | -0.96 | -0.54 | -0.28 | -0.56 | -1.17 | 0.36 | -0.51 | -1.76 | -1.10 | -0.55 | |
| 0.81 | 1.42 | 0.89 | 1.14 | 0.82 | 0.81 | 0.72 | 0.65 | 0.64 | 0.56 | 0.50 | 0.52 | |
| 1.33 | -7.37 | -2.91 | -1.75 | 1.49 | -0.17 | -0.28 | -2.00 | -0.11 | -0.58 | 0.69 | -2.10 | |
| 0.00 | 0.00 | 0.00 | 0.00 | – | 0.06 | 0.38 | 0.02 | 0.08 | – | – | – | |
| -0.05 | -0.14 | -0.36 | -0.19 | -0.20 | -0.24 | -0.26 | -0.25 | -0.29 | -0.40 | -0.39 | – | |
| 0.00 | 0.00 | 2.90 | 2.76 | -2.12 | -0.03 | 1.10 | -0.02 | -0.01 | 0.00 | -2.52 | 0.00 | |
| 1.27 | 5.80 | 4.37 | 2.91 | -2.19 | -0.42 | 0.94 | 0.00 | -0.10 | -0.10 | -2.68 | -0.21 | |
| 2.10 | -2.99 | 0.07 | 1.09 | -0.59 | -0.32 | 1.10 | -0.34 | 0.73 | 0.16 | 0.95 | 1.87 | |
| -1.31 | -2.81 | -2.26 | -1.19 | -0.70 | -0.54 | -0.27 | 1.01 | 0.29 | 0.27 | 2.42 | 3.67 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.